30 closest matches · ranked by relevance
Hospital Acquired Condition
Primary: In-hospital Mortalities — 181; 265 Participants
Cancer Prevention
Primary: Composite Cancer Screening Tests up to Date — 3087; 2590; 3866 Participants — p=.025
Medical Errors · Decision Support Systems, Clinical · Diagnostic Errors
Primary: Resolution of Contextual Red Flags — 116; 240; 83; 99 Red flags — p=.91
Severe Mental Illness · Nicotine Dependence · Schizophrenia
Primary: Initiation of Smoking Cessation Treatment — 14; 24 participants — p=0.08
Chronic Kidney Diseases · Hypertension · Diabetes
Primary: Number of Participants With CKD Diagnosis — 417; 389 Participants — p=.21
Hyperlipidemia · Hypertension · Diabetes
Primary: Blood Pressure Medication Adherence — 396; 470 Participants — p=0.0103
Hypertension · Hyperlipidemia · Diabetes
Primary: Predicted Annual Rate of Change in 10-year Risk of Fatal or Nonfatal Heart Attack or Stroke — -0.59; 1.66 annualized change in 10 year % cv risk — p=<0.05
Kidney Failure, Acute
Primary: Adverse Drug Events or Potential Adverse Drug Events — 99; 104 Patient-Medication Pairs
Medication Abuse
Primary: Percentage of PDMP Checks Conducted During High-risk Prescriptions — 8187; 6322; 13360; 23328 health care encounters
Polyp · Colorectal · Colonoscopy
Primary: Specificity and Sensitivity CDSD-unaided and CDSD-aided Endoscopist Predictions of Diminutive Polyp Histology — 90.8; 90.7; 64.7; 59.5 percentage of polyps
Acute Coronary Syndrome · Myocardial Infarction
Primary: Optimisation of the Intensity of Lipid Lowering Therapy Within 16 Weeks of Index ACS — 369; 398; 145; 207 Participants
Addiction
Primary: Receipt of Brief Intervention (BI) for Drug Use at Baseline Visit — 17; 33 Participants
Opioid-use Disorder
Primary: Intervention PCP Confidence in Assessing and Treating OUD — 6; 11; 8; 1 Participants
Diabetes Mellitus, Type 2 · Congestive Heart Failure · Obstructive Pulmonary Disease
Primary: Number of Rehospitalizations Within 60 Days After Hospital Discharge — 807 rehospitalizations
Early Detection of Cancer · Lung Neoplasms
Primary: Number of Participants With Lung Cancer Screening (LCS) Care-Gap Closed — 588 Participants
Hypotension
Primary: Postoperative Acute Kidney Injury — 1333; 372; 9670; 2785 Participants
Opioid-use Disorder
Primary: Number of Patients With OUD Diagnosis — 36; 24 participants — p=<0.05
Gastrointestinal Hemorrhage
Primary: Median Change in Attitudes Towards Machine Learning Algorithms in Clinical Care Using UTAUT — 0.0; 0.0; 0.0; 0.3 units on a scale
Colorectal Cancer
Primary: Number of Participants Reporting Preferred Screening Type as Reported by Chart Audits — 111; 99 participants
Pulmonary Embolism
Primary: Percentage of Patient Visits Where the Provider Adopted the Pulmonary Embolism Risk Kalculator (PERK) Tool — 39.11; 20.66 Percentage of Patient Visits
Depression · Low Back Pain
Primary: Change in Braddock's Informed Decision Making Score — 2.00; 1.25; 1.00; 3.20 score on a scale
Down Syndrome
Primary: Number of Participants With Indicated Evaluations That Were Completed or Recommended by the PCP — 69; 79; 36; 31 participants — p=0.018
Appendicitis
Primary: Pre to Post Ratio of Image Use — 1.13; 1.07; 1.03; 1.01 ratio of pre-post use
Hypertension · Diabetes · Hypercholesterolemia
Primary: Detection of Medical Problems (by Number of Problems Reported by Computer Assisted History, That Were Not Reported by Physician Taken History) — 98 medical problems
Clinical Decision Support · Buprenorphine · Opioid-use Disorder
Primary: Count of Initiating BUP in the ED With Referral for Ongoing MOUD With User-centered CDS Compared With Usual Care — 347; 271 Participants — p=0.58
Hypertension
Primary: Blood Pressure Remeasurement — 245; 829; 1813 participants — p=<0.001
Physician Behavior
Primary: The Number of Prompts That Were Responded to — 672; 712 Participants
Atrial Fibrillation
Primary: Number of Participants With Cardiovascular Hospitalization and AF-related Emergency Department Visits — 118; 130 Participants
Alzheimer Disease and Related Dementias (ADRD)
Primary: 12-Month Cumulative Incidence of ADRD Diagnoses — 213; 134; 355 Number of new ADRD cases — p=0.006
Type1 Diabetes Mellitus
Primary: % Time Within Target Range — 57.7; 58.2 percentage of time in range